Cagrilintide standalone protocol (pre-CagriSema research)

Standalone cagrilintide before the semaglutide combination. The Phase 2 standalone data showed ~10.8% weight reduction at 26 weeks, which is the cagrilintide-alone effect.

Protocol mirrors the Phase 2 dose escalation. Useful as a baseline before combination protocols.